Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival

Lung Cancer

Volumn 85, Issue 2, 2014, Pages 239-244

  Gray, Phillip J ^a   Mak, Raymond H ^b   Yeap, Beow Y ^c   Cryer, Sarah K ^b   Pinnell, Nancy E ^b   Christianson, Laura W ^b   Sher, David J ^d   Arvold, Nils D ^b   Baldini, Elizabeth H ^b   Chen, Aileen B ^b   Kozono, David E ^b   Swanson, Scott J ^b   Jackman, David M ^b   Alexander, Brian M ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aggressive therapy; Brain metastases; Non small cell lung cancer; Oligometastases; Radiation therapy; Stereotactic radiosurgery; Whole brain radiotherapy

Indexed keywords

ADULT; AGGRESSIVE THORACIC THERAPY; ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM SURVIVAL; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; RISK FACTOR; SYNCHRONOUS BRAIN ONLY OLIGOMETASTATIC DISEASE; AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; MORTALITY; PATHOLOGY; SECONDARY; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84904127784     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.06.001     Document Type: Article

References (26)

1. Barnholtz-Sloan J.S., Sloan A.E., Davis F.G., Vigneau F.D., Lai P., Sawaya R.E. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004, 22:2865-2872.
2. Sperduto P.W., Kased N., Roberge D., Xu Z., Shanley R., Luo X., et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012, 30:419-425.
3. Billing P.S., Miller D.L., Allen M.S., Deschamps C., Trastek V.F., Pairolero P.C., et al. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg 2001, 122:548-553.
4. Bonnette P., Puyo P., Gabriel C., Giudicelli R., Regnard J.F., Riquet M., Brichon P.Y., et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 2001, 119:1469-1475.
5. Chidel M.A., Suh J.H., Greskovich J.F., Kupelian P.A., Barnett G.H. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis. Radiat Oncol Investig 1999, 7:313-319.
6. Flannery T.W., Suntharalingam M., Regine W.F., Chin L.S., Krasna M.J., Shehata M.K., et al. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery. Int J Radiat Oncol Biol Phys 2008, 72:19-23.
7. Hu C., Chang E.L., Hassenbusch S.J., Allen P.K., Woo S.Y., Mahajan A., et al. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Cancer 2006, 106:1998-2004.
8. Lind J.S., Lagerwaard F.J., Smit E.F., Postmus P.E., Slotman B.J., Senan S. Time for reappraisal of extracranial treatment options? Synchronous brain metastases from nonsmall cell lung cancer. Cancer 2011, 117:597-605.
9. Fine J., Gray R. A proportional hazard model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
10. Halasz L.M., Weeks J.C., Neville B.A., Taback N., Punglia R.S. Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys 2013, 85:e109-e116.
11. Ashworth A., Rodrigues G., Boldt G., Palma D. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature. Lung Cancer 2013, 82:197-203.
12. Getman V., Devyatko E., Dunkler D., Eckersberger F., End A., Klepetko W., et al. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment. Eur J Cardiothorac Surg 2004, 25:1107-1113.
13. Lo C.K., Yu C.H., Ma C.C., Ko K.M., Leung S.C. Surgical management of primary non-small-cell carcinoma of lung with synchronous solitary brain metastasis: local experience. Hong Kong Med J 2010, 16:186-191.
14. Magilligan D.J., Duvernoy C., Malik G., Lewis J.W., Knighton R., Ausman J.I. Surgical approach to lung cancer with solitary cerebral metastasis: twenty-five years' experience. Ann Thorac Surg 1986, 42:360-364.
15. Mussi A., Pistolesi M., Lucchi M., Janni A., Chella A., Parenti G., et al. Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. J Thorac Cardiovasc Surg 1996, 112:146-153.
16. Rossi N.P., Zavala D.C., VanGilder J.C. A combined surgical approach to non-oat-cell pulmonary carcinoma with single cerebral metastasis. Respiration 1987, 51:170-178.
17. Ettinger D.S., Akerley W., Borghaei H., Chang A.C., Cheney R.T., Chirieac L.R., et al. Non-small cell lung cancer version 2.2013. J Natl Compr Canc Netw 2013, 11:645-653.
18. De Ruysscher D., Wanders R., van Baardwijk A., Dingemans A.M., Reymen B., Houben R., et al. Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450). J Thorac Oncol 2012, 7:1547-1555.
19. Peters S., Adjei A.A., Gridelli C., Reck M., Kerr K., Felip E., et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012, 23(Suppl. 7):vii56-vii64.
20. Arrieta O., Villarreal-Garza C., Zamora J., Blake-Cerda M., de la Mata M.D., Zavala D.G., et al. Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation. Radiat Oncol 2011, 6:166.
21. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
22. Patchell R.A., Tibbs P.A., Walsh J.W., Dempsey R.J., Maruyama Y., Kryscio R.J., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500.
23. Aoyama H., Shirato H., Tago M., Nakagawa K., Toyoda T., Hatano K., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295:2483-2491.
24. Kocher M., Soffietti R., Abacioglu U., Villà S., Fauchon F., Baumert B.G., et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2011, 29:134-141.
25. Patchell R.A., Tibbs P.A., Regine W.F., Dempsey R.J., Mohiuddin M., Kryscio R.J., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485-1489.
26. Ampil F., Caldito G., Milligan S., Mills G., Nanda A. The elderly with synchronous non-small cell lung cancer and solitary brain metastasis: does palliative thoracic radiotherapy have a useful role. Lung Cancer 2007, 57:60-65.